Intensity Modulated Radiotherapy (IMRT) Versus Helical Tomotherapy (HT) in Esophageal Cancer: A Comparative Analysis
暂无分享,去创建一个
G. Bora | Moumita Paul | Fahim Arman Hassan | D. Saikia | B. Goswami | S. Goswami | Rheetwik Baruah | L. Borah | Manasa Penumur | Diplu Choudhury | Kalyanjit Dutta Baruah | Smriti Goswami | M. Penumur | D. Choudhury | F. A. Hassan
[1] H. Ma,et al. [Dosimetric comparison of the helical tomotherapy, intensity-modulated radiotherapy and volumetric-modulated arc therapy in radical radiotherapy for esophageal cancer]. , 2019, Zhonghua yi xue za zhi.
[2] T. Mizowaki,et al. Long-term outcome of definitive radiotherapy for cervical esophageal squamous cell carcinoma , 2018, Radiation oncology.
[3] C. Chien,et al. Treatment Outcomes of Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy , 2017, Scientific Reports.
[4] Daniel T Chang,et al. Expert Consensus Contouring Guidelines for Intensity Modulated Radiation Therapy in Esophageal and Gastroesophageal Junction Cancer. , 2015, International journal of radiation oncology, biology, physics.
[5] S. Yang,et al. Radiotherapy for Esophageal Cancer Using Simultaneous Integrated Boost Techniques: Dosimetric Comparison of Helical TomoTherapy, Volumetric-Modulated Arc Therapy (RapidArc) and Dynamic Intensity-Modulated Radiotherapy , 2013, Technology in cancer research & treatment.
[6] Jeff Z. Y. Chen,et al. Dosimetric comparison of helical tomotherapy, RapidArc, and a novel IMRT & Arc technique for esophageal carcinoma. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[7] Mike Oliver,et al. Comparing planning time, delivery time and plan quality for IMRT, RapidArc and tomotherapy , 2009, Journal of applied clinical medical physics.
[8] Hisao Ito,et al. Late toxicity after definitive concurrent chemoradiotherapy for thoracic esophageal carcinoma. , 2009, International journal of radiation oncology, biology, physics.
[9] M. McAleer,et al. Principles and techniques of radiation therapy for esophageal and gastroesophageal junction cancers. , 2008, Journal of the National Comprehensive Cancer Network : JNCCN.
[10] Charles S Mayo,et al. Hybrid IMRT for treatment of cancers of the lung and esophagus. , 2008, International journal of radiation oncology, biology, physics.
[11] R. Mohan,et al. Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy. , 2008, International journal of radiation oncology, biology, physics.
[12] Yi-Jen Chen,et al. Helical tomotherapy for radiotherapy in esophageal cancer: a preferred plan with better conformal target coverage and more homogeneous dose distribution. , 2007, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.
[13] Tae Hyun Kim,et al. Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer. , 2005, Radiology.
[14] Michael Lock,et al. Prediction of radiation pneumonitis by dose - volume histogram parameters in lung cancer--a systematic review. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[15] Robert Jeraj,et al. Radiation characteristics of helical tomotherapy. , 2004, Medical physics.
[16] Narikazu Boku,et al. Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] G. Noël,et al. INT 0123 (Radiation Therapy Oncology Group 94-05) Phase III Trial of Combined-Modality Therapy for Esophageal Cancer: High-Dose Versus Standard-Dose Radiation Therapy , 2002 .
[18] R. Ginsberg,et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] J. Cooper,et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. , 1999, JAMA.
[20] M. Oldham,et al. A comparison of conventional and conformal radiotherapy of the oesophagus: work in progress. , 1998, The British journal of radiology.
[21] J. Cooper,et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] S. Law. Chemoradiotherapy - panacea for esophageal cancer? Commentary for 'Chemoradiotherapy of locally advanced esophageal cancer. Long-term follow-up of a prospective randomized trial (RTOG 85-01)' , 1999 .
[23] S. Parlee,et al. This Work Is Licensed under a Creative Commons Attribution-noncommercial 4.0 International License , 2022 .